When a disease-associated gene is mutated, is the cellular activity of its protein product enhanced or reduced? For at least one neurodegenerative disease, spinocerebellar ataxia 1, the answer seems to be both.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Journal of Natural Medicines Open Access 08 July 2020
Scientific Reports Open Access 16 April 2019
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Orr, H. T. & Zoghbi, H. Y. Annu. Rev. Neurosci. 30, 575–621 (2007).
Katsuno, M. et al. Exp. Neurol. 200, 8–18 (2006).
Li, S. & Li, X.-J. Mol. Neurodegen. 1, 19 (2006).
Lim, J. et al. Nature 452, 713–718 (2008).
Bates, G. P., Mangiarini, L. & Davies, S. W. Brain Pathol. 8, 699–714 (1998).
Lam, Y. C. et al. Cell 127, 1335–1347 (2006).
Shao, J. & Diamond, M. I. Human Mol. Genet. 16, R115–R123 (2007).
Zuccato, C. et al. J. Neurosci. 27, 6972–6983 (2007).
Kaltenbach, L. S. et al. PLoS Genet. 3, e82 (2007).
About this article
Cite this article
Thompson, L. A question of balance. Nature 452, 707–708 (2008). https://doi.org/10.1038/452707a
This article is cited by
Journal of Natural Medicines (2020)
Scientific Reports (2019)
Tissue-Specific Upregulation of Drosophila Insulin Receptor (InR) Mitigates Poly(Q)-Mediated Neurotoxicity by Restoration of Cellular Transcription Machinery
Molecular Neurobiology (2019)
Acta Neurologica Belgica (2019)
Journal of Biosciences (2014)